Constant infusion H215O PET and acetazolamide challenge in the assessment of 
the cerebral perfusion status

Weber, B; Westera G, Treyer V, Burger C, Kahn, N; Buck, A

Item

ITEM ACTIONSEXPORT

Add to Basket

Please note that a newer version of this item is available:
https://pure.mpg.de/pubman/item/item_1792100_4

DetailsSummary

Released

Journal Article

Constant infusion H215O PET and acetazolamide challenge in the assessment of the cerebral perfusion status

MPS-Authors

/persons/resource/persons84304

Weber, B
Department Physiology of Cognitive Processes, Max Planck Institute for Biological Cybernetics, Max Planck Society;

External Resource

No external resources are shared

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

There are no public fulltexts stored in PuRe

Supplementary Material (public)

There is no public supplementary material available

Citation

Weber, B., Westera G, Treyer V, Burger C, Kahn, N., & Buck, A. (2004). Constant infusion H215O PET and acetazolamide challenge in the assessment of the cerebral perfusion status. Journal of Nuclear Medicine, (45), 1344-1349.

Cite as: https://hdl.handle.net/11858/00-001M-0000-0013-DA59-C

Abstract

There is no abstract available